Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Ca (Q43916617)
scientific article published in February 1993
Language:
Current Data About Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Ca
(P31) (Q13442814)
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P304) 45-74
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P478) 14
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P577) Monday, February 1, 1993
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P921) (Q172)

(Q844935)
(P887)

(Q12252367)
(P887)

(P1433) (Q5164971)
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P1476) "Design features of a controlled clinical trial to assess the effect of an HMG CoA reductase inhibitor on the progression of coronary artery disease. Canadian Coronary Atherosclerosis Intervention Trial Investigators Montreal, Ottawa, and Toronto, Ca" (language: en)
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

(P2093) Waters D
(P1545) 1
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

Higginson L
(P1545) 2
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

Gladstone P
(P1545) 3
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

Kimball B
(P1545) 4
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

LeMay M
(P1545) 5
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

Lespérance J
(P1545) 6
(P248)
(P698) 8440094
(P813) Tuesday, November 28, 2017

other details
description scientific article published in February 1993

External Links
(P356) 10.1016/0197-2456(93)90049-J
(P698) 8440094